2024
Ixekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study
Danve A, Vadhariya A, Lisse J, Cholayil A, Bansal N, Bello N, Bakewell C. Ixekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study. Rheumatology And Therapy 2024, 11: 1333-1345. PMID: 39162898, PMCID: PMC11422398, DOI: 10.1007/s40744-024-00710-0.Peer-Reviewed Original ResearchHealth care resource utilizationFollow-up periodTumor necrosis factor-alpha inhibitorsTreatment patternsAxial spondyloarthritisPre-indexMethodsThis retrospective cohort studyBiologic-experienced patientsCharlson Comorbidity Index scoreRetrospective cohort studyClaims database studyIntroductionReal-world dataAssessed patient demographicsComorbidity Index scoreHigher comorbidity burdenProportion of daysBiologic-experiencedPatient demographicsClinical characteristicsIxekizumabIndex dateCohort studyPharmacy enrollmentEmergency room visitsAxSpAHow to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice
Kumthekar A, Sanghavi N, Natu A, Danve A. How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice. Current Rheumatology Reports 2024, 26: 170-177. PMID: 38372873, DOI: 10.1007/s11926-024-01141-0.Peer-Reviewed Original ResearchBath Ankylosing Spondylitis Disease Activity IndexElectronic patient-reported outcome measuresDisease activity measuresAssessment of disease activityC-reactive proteinDisease activityAxial spondyloarthritisDisease activity of axial spondyloarthritisClinical practicePatient-Reported Outcomes Measurement Information SystemOutcomes Measurement Information SystemOutcome measuresAnkylosing Spondylitis Disease Activity IndexIntegration of electronic health recordsMonitoring of disease activitySymptoms of axSpATreatment of axSpA.Patient-reported outcome measuresMeasurement Information SystemAxSpA disease activityElectronic health recordsMonitoring disease activityDisease activity indexLong-term outcomesPatient-reported data
2020
Assessing rheumatologists’ attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort
Rich-Garg N, Danve A, Choi D, Vakil-Gilani K, Akkoc N, Azevedo V, Russell A, Sharma A, Cush J, Curtis JR, Deodhar A. Assessing rheumatologists’ attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort. Clinical Rheumatology 2020, 40: 949-954. PMID: 32797363, DOI: 10.1007/s10067-020-05308-9.Peer-Reviewed Original ResearchRecognizing Axial Spondyloarthritis: A Guide for Primary Care
Magrey MN, Danve AS, Ermann J, Walsh JA. Recognizing Axial Spondyloarthritis: A Guide for Primary Care. Mayo Clinic Proceedings 2020, 95: 2499-2508. PMID: 32736944, DOI: 10.1016/j.mayocp.2020.02.007.Peer-Reviewed Original ResearchConceptsInflammatory back painBack painAxial spondyloarthritisHuman leukocyte antigen-B27 positivityChronic low back painNonsteroidal anti-inflammatory drugsExtra-articular manifestationsAge 45 yearsChronic back painLow back painAnti-inflammatory drugsEnglish-language articlesButtock painMorning stiffnessPeripheral arthritisSymptom onsetB27 positivityInsidious onsetAxial SpASpA featuresPrimary careEarly recognitionActive axSpAEffective therapyFamily history
2019
Harnessing the power of social media: how can it help in axial spondyloarthritis research?
Reuter K, Danve A, Deodhar A. Harnessing the power of social media: how can it help in axial spondyloarthritis research? Current Opinion In Rheumatology 2019, 31: 321-328. PMID: 31045949, DOI: 10.1097/bor.0000000000000614.Peer-Reviewed Original ResearchConceptsChronic inflammatory rheumatic diseasesInflammatory rheumatic diseasesPatient-generated health dataDelivery of careMiddle-aged adultsMost patientsAxSpA patientsRheumatic diseasesStudy enrollmentAxial spondyloarthritisDisease experienceHealth educationSpondyloarthritis ResearchStudy participantsClinical researchStudy designPatientsRheumatologyHealth dataPromising studiesFurther explorationSpondyloarthritisAxSpARheumatologists
2018
Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities
Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clinical Rheumatology 2018, 38: 625-634. PMID: 30588555, DOI: 10.1007/s10067-018-4397-3.Peer-Reviewed Original ResearchConceptsDiagnostic delayBack painAxial spondyloarthritisChronic inflammatory rheumatic diseasesPoor long-term outcomesInflammatory rheumatic diseasesChronic back painLong-term outcomesPrimary care physiciansPublic health initiativesQuality of lifeEarly referralPain clinicCare physiciansRheumatic diseasesAcute careSpA featuresPrimary careDiagnostic challengeSacroiliac jointSpinal functionPhysical therapyEarly diagnosisAxSpAPopulation prevalenceComplementary medicine for axial spondyloarthritis
Danve A, Deodhar A. Complementary medicine for axial spondyloarthritis. Current Opinion In Rheumatology 2018, 30: 310-318. PMID: 29634580, DOI: 10.1097/bor.0000000000000513.Peer-Reviewed Original ResearchConceptsCAM therapiesMind-body techniquesClinical trialsGood quality clinical trialsTrial of yogaStrong placebo effectMajority of patientsAlternative medicine (CAM) therapiesQuality clinical trialsManagement of axSpAUse of yogaDeep tissue massageAvailable scientific evidenceTui NaAdvanced diseaseDisease activityExercise programAxial spondyloarthritisFecal transplantTai ChiSide effectsPlacebo effectSmall studyComplementary medicineControl group
2017
Treat to Target in Axial Spondyloarthritis: What Are the Issues?
Danve A, Deodhar A. Treat to Target in Axial Spondyloarthritis: What Are the Issues? Current Rheumatology Reports 2017, 19: 22. PMID: 28386759, DOI: 10.1007/s11926-017-0648-6.Peer-Reviewed Original ResearchConceptsT2T strategyAxial spondyloarthritisT2TPsoriatic Arthritis TrialRandomized clinical studyChronic medical conditionsLimited therapeutic optionsRoutine clinical practiceT strategyLack of evidenceAggressive managementPsoriatic arthritisRadiographic outcomesRheumatic diseasesRheumatoid arthritisClinical evidenceTherapeutic optionsArthritis trialsClinical trialsClinical studiesMedical conditionsClinical practiceTarget strategyArthritisSpondyloarthritis
2015
Screening and referral for axial spondyloarthritis—need of the hour
Danve A, Deodhar A. Screening and referral for axial spondyloarthritis—need of the hour. Clinical Rheumatology 2015, 34: 987-993. PMID: 25946983, DOI: 10.1007/s10067-015-2958-2.Peer-Reviewed Original ResearchConceptsChronic back painBack painReferral strategiesMechanical back painSelection of patientsPrimary care physiciansRehabilitation medicine physiciansManagement of axSpAEffective therapeutic agentAge of onsetPrompt diagnosisCare physiciansRheumatoid arthritisAxial spondyloarthritisAppropriate treatmentClinical studiesReferring providerEarly diagnosisMedicine physiciansGeneral populationSpondyloarthritis featuresSpine surgeonsPatientsPhysical therapistsPainIL-17 Inhibition in Axial Spondyloarthritis
Danve A, Deodhar A. IL-17 Inhibition in Axial Spondyloarthritis. Current Treatment Options In Rheumatology 2015, 1: 221-230. DOI: 10.1007/s40674-015-0020-9.Peer-Reviewed Original ResearchIL-23/ILIL-17IL-23Monoclonal antibodiesExtra-articular manifestationsTNF-α blockadeIL-17 inhibitionIL-23 receptorQuality of lifeSignificant beneficial effectDisease activityProspective trialRadiographic progressionInhibitor medicationIL-12MRI scoresPhysical functionAxial spondyloarthritisClinical studiesP40 subunitAnimal modelsBeneficial effectsWestern populationsNovel optionSpondyloarthritis